In this article, we will discuss Toremifene (Dosage Overview). So, let’s get started.
Toremifene is an estrogen agonist/antagonist indicated for the treatment of metastatic breast cancer in
postmenopausal women with estrogen-receptor positive or unknown tumors.
The dosage of Toremifene is 60 mg, once daily, orally. Treatment is generally continued until disease progression is observed.